CHCHD10 and amyotrophic lateral sclerosis: The estimated prevalence of CHCHD10 mutations is 7.7% among FTD in a Chinese cohort [17] and 0.68–2.6% among FTD–ALS patients of European descent [11,12,13,14,15,16].